Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
palovarotene — Retinoic acid receptor-γ Interaction
Drug-target interaction between palovarotene and Retinoic acid receptor-γ. Synthetic organic pharmacological agent targeting this protein.
pamidronic acid — farnesyl diphosphate synthase Interaction
Drug-target interaction between pamidronic acid and farnesyl diphosphate synthase. Synthetic organic pharmacological agent targeting this protein.
pancuronium — nicotinic acetylcholine receptor α1 subunit Interaction
Drug-target interaction between pancuronium and nicotinic acetylcholine receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
panitumumab — epidermal growth factor receptor Interaction
Drug-target interaction between panitumumab and epidermal growth factor receptor. Antibody pharmacological agent targeting this protein.
paricalcitol — Vitamin D receptor Interaction
Drug-target interaction between paricalcitol and Vitamin D receptor. Metabolite pharmacological agent targeting this protein.
paroxetine — SERT Interaction
Drug-target interaction between paroxetine and SERT. Synthetic organic pharmacological agent targeting this protein.
pasireotide — SST1 receptor Interaction
Drug-target interaction between pasireotide and SST1 receptor. Peptide pharmacological agent targeting this protein.
pasireotide — SST2 receptor Interaction
Drug-target interaction between pasireotide and SST2 receptor. Peptide pharmacological agent targeting this protein.
pasireotide — SST3 receptor Interaction
Drug-target interaction between pasireotide and SST3 receptor. Peptide pharmacological agent targeting this protein.
pasireotide — SST5 receptor Interaction
Drug-target interaction between pasireotide and SST5 receptor. Peptide pharmacological agent targeting this protein.
pazopanib — fms related receptor tyrosine kinase 1 Interaction
Drug-target interaction between pazopanib and fms related receptor tyrosine kinase 1. Synthetic organic pharmacological agent targeting this protein.
pazopanib — fms related receptor tyrosine kinase 4 Interaction
Drug-target interaction between pazopanib and fms related receptor tyrosine kinase 4. Synthetic organic pharmacological agent targeting this protein.
pazopanib — kinase insert domain receptor Interaction
Drug-target interaction between pazopanib and kinase insert domain receptor. Synthetic organic pharmacological agent targeting this protein.
pegfilgrastim — Granulocyte colony-stimulating factor receptor Interaction
Drug-target interaction between pegfilgrastim and Granulocyte colony-stimulating factor receptor. Peptide pharmacological agent targeting this protein.
peginesatide — Eythropoietin receptor Interaction
Drug-target interaction between peginesatide and Eythropoietin receptor. Peptide pharmacological agent targeting this protein.
peginterferon alfa-2b — interferon α/β receptor 1 Interaction
Drug-target interaction between peginterferon alfa-2b and interferon α/β receptor 1. Peptide pharmacological agent targeting this protein.
peginterferon alfa-2b — Interferon-α/β receptor Interaction
Drug-target interaction between peginterferon alfa-2b and Interferon-α/β receptor. Peptide pharmacological agent targeting this protein.
pegvisomant — Growth hormone receptor Interaction
Drug-target interaction between pegvisomant and Growth hormone receptor. Peptide pharmacological agent targeting this protein.
pembrolizumab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between pembrolizumab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
pemetrexed — dihydrofolate reductase Interaction
Drug-target interaction between pemetrexed and dihydrofolate reductase. Synthetic organic pharmacological agent targeting this protein.
pentostatin — Adenosine deaminase Interaction
Drug-target interaction between pentostatin and Adenosine deaminase. Synthetic organic pharmacological agent targeting this protein.
perindopril — Angiotensin-converting enzyme Interaction
Drug-target interaction between perindopril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
perindoprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between perindoprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
perospirone — D2 receptor Interaction
Drug-target interaction between perospirone and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
perospirone — D3 receptor Interaction
Drug-target interaction between perospirone and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
perospirone — D4 receptor Interaction
Drug-target interaction between perospirone and D4 receptor. Synthetic organic pharmacological agent targeting this protein.
perphenazine — D2 receptor Interaction
Drug-target interaction between perphenazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
pertuzumab — erb-b2 receptor tyrosine kinase 2 Interaction
Drug-target interaction between pertuzumab and erb-b2 receptor tyrosine kinase 2. Antibody pharmacological agent targeting this protein.
pethidine — μ receptor Interaction
Drug-target interaction between pethidine and μ receptor. Synthetic organic pharmacological agent targeting this protein.
pexidartinib — colony stimulating factor 1 receptor Interaction
Drug-target interaction between pexidartinib and colony stimulating factor 1 receptor. Synthetic organic pharmacological agent targeting this protein.
pexidartinib — KIT proto-oncogene, receptor tyrosine kinase Interaction
Drug-target interaction between pexidartinib and KIT proto-oncogene, receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
PGE1 — EP1 receptor Interaction
Drug-target interaction between PGE1 and EP1 receptor. Metabolite pharmacological agent targeting this protein.
PGE1 — EP2 receptor Interaction
Drug-target interaction between PGE1 and EP2 receptor. Metabolite pharmacological agent targeting this protein.
PGE2 — EP1 receptor Interaction
Drug-target interaction between PGE2 and EP1 receptor. Metabolite pharmacological agent targeting this protein.
PGE2 — EP2 receptor Interaction
Drug-target interaction between PGE2 and EP2 receptor. Metabolite pharmacological agent targeting this protein.
PGI2 — EP1 receptor Interaction
Drug-target interaction between PGI2 and EP1 receptor. Metabolite pharmacological agent targeting this protein.
phenelzine — Monoamine oxidase A Interaction
Drug-target interaction between phenelzine and Monoamine oxidase A. Synthetic organic pharmacological agent targeting this protein.
phenelzine — Monoamine oxidase B Interaction
Drug-target interaction between phenelzine and Monoamine oxidase B. Synthetic organic pharmacological agent targeting this protein.
phenindione — vitamin K epoxide reductase complex subunit 1 Interaction
Drug-target interaction between phenindione and vitamin K epoxide reductase complex subunit 1. Synthetic organic pharmacological agent targeting this protein.
phenoxybenzamine — α2B-adrenoceptor Interaction
Drug-target interaction between phenoxybenzamine and α2B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
phenprocoumon — vitamin K epoxide reductase complex subunit 1 Interaction
Drug-target interaction between phenprocoumon and vitamin K epoxide reductase complex subunit 1. Synthetic organic pharmacological agent targeting this protein.
phentolamine — α1A-adrenoceptor Interaction
Drug-target interaction between phentolamine and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
phentolamine — α1B-adrenoceptor Interaction
Drug-target interaction between phentolamine and α1B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
phentolamine — α1D-adrenoceptor Interaction
Drug-target interaction between phentolamine and α1D-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
phenylbutazone — COX-1 Interaction
Drug-target interaction between phenylbutazone and COX-1. Synthetic organic pharmacological agent targeting this protein.
phenylbutazone — COX-2 Interaction
Drug-target interaction between phenylbutazone and COX-2. Synthetic organic pharmacological agent targeting this protein.
phenylephrine — α1A-adrenoceptor Interaction
Drug-target interaction between phenylephrine and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
phenytoin — Nav1.2 Interaction
Drug-target interaction between phenytoin and Nav1.2. Synthetic organic pharmacological agent targeting this protein.
physostigmine — acetylcholinesterase (Yt blood group) Interaction
Drug-target interaction between physostigmine and acetylcholinesterase (Yt blood group). Natural product pharmacological agent targeting this protein.
pilocarpine — M3 receptor Interaction
Drug-target interaction between pilocarpine and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
pimavanserin — 5-HT2A receptor Interaction
Drug-target interaction between pimavanserin and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
pimecrolimus — FKBP prolyl isomerase 1A Interaction
Drug-target interaction between pimecrolimus and FKBP prolyl isomerase 1A. Synthetic organic pharmacological agent targeting this protein.
pimozide — 5-HT2A receptor Interaction
Drug-target interaction between pimozide and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
pimozide — D2 receptor Interaction
Drug-target interaction between pimozide and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
pindolol — β1-adrenoceptor Interaction
Drug-target interaction between pindolol and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
pindolol — β2-adrenoceptor Interaction
Drug-target interaction between pindolol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
pioglitazone — Peroxisome proliferator-activated receptor-γ Interaction
Drug-target interaction between pioglitazone and Peroxisome proliferator-activated receptor-γ. Synthetic organic pharmacological agent targeting this protein.
pipotiazine — D2 receptor Interaction
Drug-target interaction between pipotiazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
pirenzepine — M1 receptor Interaction
Drug-target interaction between pirenzepine and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
piroxicam — COX-1 Interaction
Drug-target interaction between piroxicam and COX-1. Synthetic organic pharmacological agent targeting this protein.